Göğüse futbol topu çarpması sonrası senkop geçiren ve atriyoventriküler tam blokun eşlik ettiği hipertrofik nonobstrüktif kardiyomiyopatili bir olguda takılabilir kardiyoverter defibrilatör uygulaması

Year 2012, Volume: 19 Issue: 1, 25 - 28, 30.03.2012

Mehmet Özaydın , Selahattin Akçay Yasin Türker Atilla İçli

Abstract

Hipertrofik kardiyomiyopati (HKM), kompleks, sık rastlanılan, klinik seyir ve semptomları çoğu zaman çeşitlilik gösteren genetik kardiyak bir hastalıktır. Bu yazıda futbol topu çarpması sonrası senkop geçiren, AV tam blokun eşlik ettiği hipertrofik nonobstrüktif kardiyomiyopatili bir olguda takılabilir kardiyoverter defibrilatör uygulaması sunuldu.
Anahtar kelimeler: Hipertrofik Kardiyomiyopati, Takılabilir Kardiyoverter Defibrilatör, Senkop

Abstract

Implantable cardioverter defibrillator implantation in a patient with nonobstructive hypertrophic cardiomyopathy associated A-V complete block presenting with syncope after football hit to the chest

Hypertrophic cardiomyopathy (HCM) is a complex and relatively common genetic cardiac disorder with heterogeneous clinical course and expression. We reported a case with implantable cardioverter defibrillator implantation in a patient with nonobstructive hypertrophic cardiomyopathy associated A-V complete block presenting with syncope after football hit to the chest.

Key words: Hypertrophic Cardiomyopathy, Implantable Cardioverter Defibrillator, Syncope

Keywords

Hipertrofik Kardiyomiyopati, Takýlabilir Kardiyoverter Defibrilatör, Senkop

References

• Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93(5):841-2.
• Ingham RE, Mason JW, Rossen RM, Goodman DJ, Harrison DC. Electrophysiologic findings in patients with idiopathic hypertrophic subaortic stenosis. 1978; 41(5): 811-6.
• Cotiga, D, Ehlert,F, Sherrid, MV. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy. Anadolu Kardiyol Derg 2006; 6(Suppl 2): 55-60.
• Hart G. Exercise-induced cardiac hypertrophy:a substrate for sudden death in athletes? Exp Physiol 2003; 88(5): 639-644.
• Lampert R, Cannom D, Olshansky B. Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members. J Cardiovasc Electrophysiol. 2006;17(1):11-5.
• Boden BP, Tacchetti R, Mueller FO. Catastrophic injuries in high school and college baseball players. Am J Sports Med. 2004;32(5):1189-96.
• Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336(11):775-785.
• Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42(9):1687–713.
• Fananapazir L, Epstein SE. Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am J Cardiol 1991;67(4):280-7.
• Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36(7):2212-8.
• Maron BJ, Poliac LC, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med. 1995 ;333(6):337-42.
• Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339(14):960-5.